Brief Intervention for Self-Harm in Veterans

(STRIVe Trial)

Overseen By Angela C Kirby, MS

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: VA Office of Research and Development

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 9

Duration: 9 weeks

40 Participants Needed

Trial Summary

What is the purpose of this trial?

This trial is testing a therapy called T-SIB to help Veterans who hurt themselves on purpose. The therapy teaches healthier ways to cope and uses real-time tracking to understand and manage triggers. Veterans are targeted because they have higher rates of self-injury, which can lead to serious mental health problems.

Research Team

Tate F Halverson, PhD

Principal Investigator

Durham VA Medical Center, Durham, NC

Eligibility Criteria

This trial is for Veterans aged 18 or older who have harmed themselves on purpose at least twice in the past month without suicidal intent. Participants must be fluent in English and able to consent to the study. Those with a history of psychosis, mania, hypomania, or current high risk of suicide or homicide are not eligible.

Inclusion Criteria

I am 18 years old or older.

Fluent in English

Past service in the United States military

Exclusion Criteria

I cannot or do not want to follow the study's required procedures.

Lifetime history of psychosis, mania, or hypomania

Imminent risk for suicide/homicide warranting immediate intervention

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive nine sessions of Treatment for Self-Injurious Behaviors (T-SIB) to reduce NSSI and improve psychosocial functioning

9 weeks

9 sessions (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

• Treatment As Usual
• Treatment for Self-Injurious Behaviors

Trial Overview The study is testing a brief intervention designed to reduce self-harm behaviors and improve psychosocial functioning among Veterans. It will compare this new approach against the usual treatment methods typically offered for self-injury.

Participant Groups

Group I: T-SIB Experimental Treatment 1 Intervention

Participants randomized to the Treatment for Self-Injurious Behaviors (T-SIB) condition will receive nine sessions of T-SIB.

Group II: Treatment As Usual Active Control 1 Intervention

Participants randomized to the TAU condition will be provided with referrals to both Durham VA and local community mental health resources and offered a consult for Durham VA mental health services.

Who Is Running the Clinical Trial?

VA Office of Research and Development

Lead Sponsor

Trials

1,691

Recruited

3,759,000+